Suppr超能文献

肺炎支原体中磷酸烯醇丙酮酸:糖磷酸转移酶系统的酶促和调节成分的体内活性

In vivo activity of enzymatic and regulatory components of the phosphoenolpyruvate:sugar phosphotransferase system in Mycoplasma pneumoniae.

作者信息

Halbedel Sven, Hames Claudine, Stülke Jörg

机构信息

Department of General Microbiology, Institute of Microbiology and Genetics, Georg-August University Göttingen, Grisebachstr. 8, D-37077 Göttingen, Germany.

出版信息

J Bacteriol. 2004 Dec;186(23):7936-43. doi: 10.1128/JB.186.23.7936-7943.2004.

Abstract

Mycoplasma pneumoniae is a pathogenic bacterium that is highly adapted to life on mucosal surfaces. This adaptation is reflected by the very compact genome and the small number of regulatory proteins. However, M. pneumoniae possesses the HPr kinase/phosphorylase (HPrK/P), the key regulator of carbon metabolism in the Firmicutes. In contrast to the enzymes of other bacteria, the HPrK/P of M. pneumoniae is already active at very low ATP concentrations, suggesting a different mode of regulation. In this work, we studied the ability of M. pneumoniae to utilize different carbohydrates and their effects on the activity of the different phosphotransferase system (PTS) components. Glucose served as the best carbon source, with a generation time of about 30 h. Fructose and glycerol were also used but at lower rates and with lower yields. In contrast, M. pneumoniae is unable to use mannitol even though the bacterium is apparently equipped with all the genes required for mannitol catabolism. This observation is probably a reflection of the continuing and ongoing reduction of the M. pneumoniae genome. The general enzymatic and regulatory components of the PTS, i.e., enzyme I, HPr, and HPrK/P, were present under all growth conditions tested in this study. However, HPrK/P activity is strongly increased if the medium contains glycerol. Thus, the control of HPrK/P in vivo differs strongly between M. pneumoniae and the other Firmicutes. This difference may relate to the specific conditions on lipid-rich cell surfaces.

摘要

肺炎支原体是一种高度适应在粘膜表面生存的致病细菌。这种适应性体现在其非常紧凑的基因组和少量的调节蛋白上。然而,肺炎支原体拥有HPr激酶/磷酸化酶(HPrK/P),这是厚壁菌门中碳代谢的关键调节因子。与其他细菌的酶不同,肺炎支原体的HPrK/P在非常低的ATP浓度下就已经具有活性,这表明其调节方式不同。在这项研究中,我们研究了肺炎支原体利用不同碳水化合物的能力及其对不同磷酸转移酶系统(PTS)组分活性的影响。葡萄糖是最佳碳源,代时约为30小时。也使用了果糖和甘油,但利用率较低且产量较低。相比之下,肺炎支原体不能利用甘露醇,尽管该细菌显然具备了甘露醇分解代谢所需的所有基因。这一观察结果可能反映了肺炎支原体基因组的持续且正在进行的缩减。在本研究测试的所有生长条件下,PTS的一般酶促和调节组分,即酶I、HPr和HPrK/P均存在。然而,如果培养基中含有甘油,HPrK/P的活性会显著增加。因此,肺炎支原体与其他厚壁菌门在体内对HPrK/P的调控差异很大。这种差异可能与富含脂质的细胞表面的特定条件有关。

相似文献

2
A novel mode of control of Mycoplasma pneumoniae HPr kinase/phosphatase activity reflects its parasitic lifestyle.
Microbiology (Reading). 2002 Oct;148(Pt 10):3277-3284. doi: 10.1099/00221287-148-10-3277.
4
Mycoplasma pneumoniae HPr kinase/phosphorylase.
Eur J Biochem. 2004 Jan;271(2):367-74. doi: 10.1046/j.1432-1033.2003.03935.x.
7
Transcription regulators potentially controlled by HPr kinase/phosphorylase in Gram-negative bacteria.
J Mol Microbiol Biotechnol. 2003;5(4):206-15. doi: 10.1159/000071072.
9
Essential role of the hprK gene in Ralstonia eutropha H16.
J Mol Microbiol Biotechnol. 2009;17(3):146-52. doi: 10.1159/000233505. Epub 2009 Aug 6.

引用本文的文献

1
A Glycerol ABC Transporter Involved in Pathogenicity.
Appl Environ Microbiol. 2021 May 11;87(11). doi: 10.1128/AEM.03112-20.
3
In-cell architecture of an actively transcribing-translating expressome.
Science. 2020 Jul 31;369(6503):554-557. doi: 10.1126/science.abb3758.
4
Characterization of an Immunoglobulin Binding Protein (IbpM) From .
Front Microbiol. 2020 Apr 16;11:685. doi: 10.3389/fmicb.2020.00685. eCollection 2020.
5
Horizontal Acquisition and Transcriptional Integration of Novel Genes in Mosquito-Associated Spiroplasma.
Genome Biol Evol. 2017 Dec 1;9(12):3246-3259. doi: 10.1093/gbe/evx244.
6
Identification of the Components Involved in Cyclic Di-AMP Signaling in .
Front Microbiol. 2017 Jul 13;8:1328. doi: 10.3389/fmicb.2017.01328. eCollection 2017.
7
The Blueprint of a Minimal Cell: MiniBacillus.
Microbiol Mol Biol Rev. 2016 Sep 28;80(4):955-987. doi: 10.1128/MMBR.00029-16. Print 2016 Dec.
8
Insights into the pathogenesis of Mycoplasma pneumoniae (Review).
Mol Med Rep. 2016 Nov;14(5):4030-4036. doi: 10.3892/mmr.2016.5765. Epub 2016 Sep 23.
9
Potential Molecular Targets for Narrow-Spectrum Agents to Combat Mycoplasma pneumoniae Infection and Disease.
Front Microbiol. 2016 Feb 25;7:205. doi: 10.3389/fmicb.2016.00205. eCollection 2016.
10
Implication of glycerol and phospholipid transporters in Mycoplasma pneumoniae growth and virulence.
Infect Immun. 2013 Mar;81(3):896-904. doi: 10.1128/IAI.01212-12. Epub 2013 Jan 7.

本文引用的文献

1
Proteogenomic mapping as a complementary method to perform genome annotation.
Proteomics. 2004 Jan;4(1):59-77. doi: 10.1002/pmic.200300511.
2
Mycoplasma pneumoniae HPr kinase/phosphorylase.
Eur J Biochem. 2004 Jan;271(2):367-74. doi: 10.1046/j.1432-1033.2003.03935.x.
3
CcpA-dependent carbon catabolite repression in bacteria.
Microbiol Mol Biol Rev. 2003 Dec;67(4):475-90. doi: 10.1128/MMBR.67.4.475-490.2003.
4
Factors determining the appearance of glucose in upper and lower respiratory tract secretions.
Intensive Care Med. 2003 Dec;29(12):2204-2210. doi: 10.1007/s00134-003-1961-2. Epub 2003 Aug 28.
6
Transcription profiles of the bacterium Mycoplasma pneumoniae grown at different temperatures.
Nucleic Acids Res. 2003 Nov 1;31(21):6306-20. doi: 10.1093/nar/gkg841.
9
Regulation and mutational analysis of the HPr kinase/phosphorylase from Bacillus subtilis.
Biochemistry. 2003 Jun 10;42(22):6762-71. doi: 10.1021/bi034405i.
10
Crystal structure of HPr kinase/phosphatase from Mycoplasma pneumoniae.
J Mol Biol. 2003 Feb 28;326(4):1203-17. doi: 10.1016/s0022-2836(02)01378-5.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验